Saito Y, Suzuki S, Sanomachi T, Kato K, Otake H, Nishise Y
In Vivo. 2025; 39(2):1173-1181.
PMID: 40010976
PMC: 11884457.
DOI: 10.21873/invivo.13921.
Notoya G, Kishikawa T, Yasugi K, Iwata T, Seimiya T, Miyabayashi K
J Gastroenterol. 2024; 60(3):370-384.
PMID: 39656237
PMC: 11880106.
DOI: 10.1007/s00535-024-02192-x.
Roy I, Binder-Markey B, Willbanks A, Sychowski D, Phipps T, Barber A
J Appl Physiol (1985). 2024; 137(3):705-717.
PMID: 39052773
PMC: 11424168.
DOI: 10.1152/japplphysiol.00173.2024.
Zaryouh H, Van Loenhout J, Peeters M, Vermorken J, Lardon F, Wouters A
Cancers (Basel). 2022; 14(24).
PMID: 36551613
PMC: 9776372.
DOI: 10.3390/cancers14246128.
Nguyen T, Silva F, Golemis E
Cancer J. 2022; 28(5):387-400.
PMID: 36165728
PMC: 9836054.
DOI: 10.1097/PPO.0000000000000614.
Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes.
Richards K, Xiao W, Hill R, The Usc Pancreas Research Team
Cancers (Basel). 2022; 14(11).
PMID: 35681792
PMC: 9179363.
DOI: 10.3390/cancers14112812.
Toward Systems Pathology for PTEN Diagnostics.
Haddadi N, Travis G, Nassif N, Simpson A, Marsh D
Cold Spring Harb Perspect Med. 2019; 10(5).
PMID: 31615872
PMC: 7197423.
DOI: 10.1101/cshperspect.a037127.
PTEN Is Associated With Worse Local Control in Early Stage Supraglottic Laryngeal Cancer Treated With Radiotherapy.
Bruine de Bruin L, Wachters J, Schrijvers M, Slagter-Menkema L, Mastik M, Langendijk J
Laryngoscope Investig Otolaryngol. 2019; 4(4):399-404.
PMID: 31453348
PMC: 6703112.
DOI: 10.1002/lio2.272.
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer.
Luongo F, Colonna F, Calapa F, Vitale S, Fiori M, De Maria R
Cancers (Basel). 2019; 11(8).
PMID: 31366089
PMC: 6721423.
DOI: 10.3390/cancers11081076.
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?.
Bazzichetto C, Conciatori F, Pallocca M, Falcone I, Fanciulli M, Cognetti F
Cancers (Basel). 2019; 11(4).
PMID: 30925702
PMC: 6520939.
DOI: 10.3390/cancers11040435.
The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
Fukusumi T, Califano J
J Dent Res. 2018; 97(6):645-653.
PMID: 29489439
PMC: 5960881.
DOI: 10.1177/0022034518760297.
Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.
Guy J, Mery B, Ollier E, Espenel S, Vallard A, Wozny A
Sci Rep. 2017; 7(1):12207.
PMID: 28939847
PMC: 5610257.
DOI: 10.1038/s41598-017-12367-7.
Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma.
Cai Y, Dodhia S, Su G
Oncotarget. 2017; 8(13):22203-22217.
PMID: 28108737
PMC: 5400658.
DOI: 10.18632/oncotarget.14729.
Genomic sequencing and precision medicine in head and neck cancers.
Hoesli R, Ludwig M, Michmerhuizen N, Rosko A, Spector M, Brenner J
Eur J Surg Oncol. 2016; 43(5):884-892.
PMID: 28034498
PMC: 5393934.
DOI: 10.1016/j.ejso.2016.12.002.
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.
Gong W, Xiao Y, Wei Z, Yuan Y, Qiu M, Sun C
Oncotarget. 2016; 8(2):2141-2152.
PMID: 27924064
PMC: 5356787.
DOI: 10.18632/oncotarget.13798.
Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.
Michmerhuizen N, Birkeland A, Bradford C, Brenner J
Genes Cancer. 2016; 7(5-6):182-200.
PMID: 27551333
PMC: 4979591.
DOI: 10.18632/genesandcancer.110.
Carbon ion irradiation withstands cancer stem cells' migration/invasion process in Head and Neck Squamous Cell Carcinoma (HNSCC).
Moncharmont C, Guy J, Wozny A, Gilormini M, Battiston-Montagne P, Ardail D
Oncotarget. 2016; 7(30):47738-47749.
PMID: 27374096
PMC: 5216975.
DOI: 10.18632/oncotarget.10281.
Molecular Aspects of Head and Neck Cancer Therapy.
Puram S, Rocco J
Hematol Oncol Clin North Am. 2015; 29(6):971-92.
PMID: 26568543
PMC: 4648693.
DOI: 10.1016/j.hoc.2015.07.003.
Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.
Sahin I, Iacobuzio-Donahue C, OReilly E
Expert Opin Ther Targets. 2015; 20(3):341-59.
PMID: 26439702
PMC: 4985526.
DOI: 10.1517/14728222.2016.1094057.
Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.
Georgy S, Cangkrama M, Srivastava S, Partridge D, Auden A, Dworkin S
J Natl Cancer Inst. 2015; 107(9).
PMID: 26063791
PMC: 4836819.
DOI: 10.1093/jnci/djv152.